I am posting my regulatory news blog early since I will be out of the office tomorrow.  Here are the top regulatory news stories this week: The U.S. FDA approved Mylan’s biosimilar of Roche’s blockbuster treatment for breast cancer, Herceptin.  This is the eighth biosimilar to be approved by the FDA:  https://www.reuters.com/article/us-mylan-nl-fda/fda-oks-mylans-biosimilar-of-roche-cancer-drug-herceptin-idUSKBN1DV5BI Sunovion received FDA[…]